OverT Bio
PrivateLast Round
Grant
Nov 22, 2024
Total Funding Raised
$16.12M
Company Overview
OverT Bio operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Grant round in November 2024.
OverT Bio is a biotechnology company that develops cell therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OverT Bio Comparables
Compare OverT Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ArsenalBio | 82% | |
| Encelta AG | 78% | |
| Acepodia | 77% |
For institutional investors. Book with your work email.
OverT Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 22, 2024 | ||||
| Seed | May 6, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OverT Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | Seed |
| Gaingels | Seed |
| ARTIS Ventures | Seed |
| Hawktail Management | Seed |
| Alexandria Venture Investments | Seed |
| OMX Ventures | Seed |
| Cancer Research Institute | Seed |
For institutional investors. Book with your work email.
OverT Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OverT Bio's valuation, stock price, and market status.
Is OverT Bio a public or private company?
OverT Bio is a private company.
What is the current stock price of OverT Bio?
OverT Bio is a private company, so its shares have no public market price. Caplight tracks OverT Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OverT Bio worth (valuation)?
Valuation information for OverT Bio is not publicly available.
Can I buy OverT Bio stock?
OverT Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OverT Bio's last funding round?
OverT Bio's most recent funding round was Grant on November 22, 2024.
Who are the main investors in OverT Bio?
Key investors in OverT Bio include ARTIS Ventures.
Will OverT Bio IPO soon?
No public IPO plans have been announced for OverT Bio.
How can I track OverT Bio secondary market activity?
Caplight tracks bids, offers, and trades in OverT Bio's shares on secondary markets.